MRSN (Mersana Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on MRSN (Mersana Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

MRSN

Mersana Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Lags Revenue Estimates
Nov 14, 2025
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
Nov 14, 2025
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Deal Worth Up to $285 Million
Nov 13, 2025
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Nov 13, 2025
Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025
Nov 10, 2025
Wall Street Analysts See a 314.81% Upside in Mersana Therapeutics (MRSN): Can the Stock Really Move This High?
Sep 8, 2025
Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet
Aug 22, 2025
Mersana Therapeutics Second Quarter 2025 Earnings: Misses Expectations
Aug 15, 2025
Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Lags Revenue Estimates
Aug 13, 2025
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
Aug 13, 2025

Reviews